Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

Published:2017-02 Issue:10069 Volume:389 Page:621-628
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zhu Feng-Cai,Wurie Alie H,Hou Li-Hua,Liang Qi,Li Yu-Hua,Russell James B W,Wu Shi-Po,Li Jing-Xin,Hu Yue-Mei,Guo Qiang,Xu Wen-Bo,Wurie Abdul R,Wang Wen-Juan,Zhang Zhe,Yin Wen-Jiao,Ghazzawi Manal,Zhang Xu,Duan Lei,Wang Jun-Zhi,Chen Wei

Funder

Chinese Ministry of Science and Technology and the National Health and Family Planning Commission

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule;Martin;Nat Rev Microbiol,2009

2. Ebola outbreak 2014–2015,2016

3. Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector;Pratt;Clin Vaccine Immunol,2010

4. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial;Kibuuka;Lancet,2015

5. Chimpanzee adenovirus vector Ebola vaccine—preliminary report;Ledgerwood;N Engl J Med,2015

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. Recent research advances in the development of Dabie Banda virus vaccines;PLOS Neglected Tropical Diseases;2024-08-29

3. Evaluation of two inoculation routes of an adenovirus-mediated viral protein inhibitor in a Crimean-Congo hemorrhagic fever mouse model;Virus Research;2024-07

4. Post COVID-19 era: Re-emergence of known and future (X) viral pathogens;Vacunas;2024-07

5. Post COVID-19 era: Re-emergence of known and future (X) viral pathogens;Vacunas (English Edition);2024-07